Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKRX

Akorn (AKRX) Stock Price, News & Analysis

Akorn logo

About Akorn Stock (NASDAQ:AKRX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.09
$0.32
52-Week Range
N/A
Volume
1.19 million shs
Average Volume
9.60 million shs
Market Capitalization
$3.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akorn and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AKRX Stock News Headlines

Akorn Reaches New 52-Week High (AKRX)
Overnight moves = possibly bigger returns
Here’s a chart everyone should see that dates back to 1993… As you can see, the top line shows the much bigger average market return from trading overnight… Versus the bottom line, which shows the more modest average return from trading during the day. Look at that gigantic difference! So if you prefer nice big overnight returns instead, I agree with you. That’s why I’ve designed a breakthrough trade to tap into that overnight trading frenzy. You can check that out right here. Obviously, I won’t make any reckless guarantees in the stock market, but… That eye-opening chart above is just the beginning of the benefits you’ll see to trading overnight. PLUS, you’ll also see what my #1 ranked asset is in the entire market… And what my “hands-off” stocks are that I wouldn’t touch with a 100-foot pole.tc pixel
See More Headlines

AKRX Stock Analysis - Frequently Asked Questions

Akorn, Inc. (NASDAQ:AKRX) posted its quarterly earnings data on Monday, May, 11th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.45. The business earned $204.69 million during the quarter, compared to analyst estimates of $168.90 million. Akorn had a positive trailing twelve-month return on equity of 8.53% and a negative net margin of 55.64%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akorn investors own include Bristol Myers Squibb (BMY), Integrated Device Technology (IDTI), Skechers U.S.A. (SKX), Rite Aid (RAD), Lannett (LCI), Bank of America (BAC) and Quantenna Communications (QTNA).

Company Calendar

Last Earnings
5/11/2020
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:AKRX
CIK
3116
Fax
N/A
Employees
2,227
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$226.77 million
Net Margins
-55.64%
Pretax Margin
N/A
Return on Equity
8.53%
Return on Assets
1.31%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
0.50
Quick Ratio
0.32

Sales & Book Value

Annual Sales
$682.43 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.19
Book Value
$1.86 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
133,152,000
Free Float
N/A
Market Cap
$3.60 million
Optionable
Optionable
Beta
0.95
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:AKRX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners